Head-To-Head Comparison: Medical Cannabis Payment Solutions (OTCMKTS:REFG) and Paymentus (NYSE:PAY)

Medical Cannabis Payment Solutions (OTCMKTS:REFG) and Paymentus (NYSE:PAY) are both business services companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, dividends, analyst recommendations, profitability, valuation and risk.

Institutional & Insider Ownership

78.4% of Paymentus shares are owned by institutional investors. 75.4% of Paymentus shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Earnings & Valuation

This table compares Medical Cannabis Payment Solutions and Paymentus”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medical Cannabis Payment Solutions	N/A	N/A	-$30,000.00	N/A	N/A
Paymentus	$871.74 million	5.07	$44.17 million	$0.46	76.58

Paymentus has higher revenue and earnings than Medical Cannabis Payment Solutions.

Analyst Ratings

This is a summary of recent recommendations and price targets for Medical Cannabis Payment Solutions and Paymentus, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medical Cannabis Payment Solutions	0	0	0	0	0.00
Paymentus	0	4	4	0	2.50

Paymentus has a consensus price target of $37.50, suggesting a potential upside of 6.45%. Given Paymentus’ stronger consensus rating and higher possible upside, analysts clearly believe Paymentus is more favorable than Medical Cannabis Payment Solutions.

Profitability

This table compares Medical Cannabis Payment Solutions and Paymentus’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Medical Cannabis Payment Solutions	N/A	N/A	N/A
Paymentus	5.29%	12.68%	10.68%

Risk and Volatility

Medical Cannabis Payment Solutions has a beta of -0.62, suggesting that its stock price is 162% less volatile than the S&P 500. Comparatively, Paymentus has a beta of 1.48, suggesting that its stock price is 48% more volatile than the S&P 500.

Summary

Paymentus beats Medical Cannabis Payment Solutions on 11 of the 11 factors compared between the two stocks.

About Medical Cannabis Payment Solutions

Medical Cannabis Payment Solutions, Inc. develops and markets a payment system for medical cannabis transactions. Its solution assists in the state tracking of sales, collection of tax, and supervision of sales to consumers. The company was incorporated in 2013 and is based in Cheyenne, Wyoming. On August 12, 2024, Medical Cannabis Payment Solutions, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Western District of Pennsylvania.

About Paymentus

Paymentus Holdings, Inc. provides cloud-based bill payment technology and solutions in the United States and internationally. The company offers electronic bill presentment and payment services, enterprise customer communication, and self-service revenue management to billers through a software-as-a-service technology platform. Its platform's payment processing includes credit cards, debit cards, eChecks, and digital wallets. It serves utility, financial service, government, insurance, telecommunication, real estate management, education, consumer finance, healthcare, and small business industries. The company was founded in 2004 and is headquartered in Charlotte, North Carolina.